Drug companies are quietly pushing through price hikes of 100% — or even more than 1,000% — for a very small but growing number of prescription drugs, helping to drive up costs for insurers, patients and government programs.
Among the examples: Questcor Pharmaceuticals last August raised the wholesale price on Acthar, which treats spasms in babies, from about $1,650 a vial to more than $23,000. Ovation raised the cost of Cosmegen, which treats a type of tumor, from $16.79 to $593.75 in January 2006.
The average wholesale price of 26 brand-name drugs jumped 100% or more in a single cost adjustment last year, up from 15 in 2004, the university study found. In the first half of this year, 17 drugs made the list.
The nation’s pre-eminent breast cancer advocacy group, the Susan G. Komen for the Cure foundation, apologized...
Sugar is as damaging and addictive as alcohol or tobacco and should be regulated, claim US...
New York City mayor Michael Bloomberg has entered the controversy over America's largest breast cancer advocacy...
In a decision that is inflaming passions on both sides of the abortion debate, the world’s...
